Torrent Pharmaceuticals Ltd Share Price (TORNTPHARM)
Check the latest share price of Torrent Pharmaceuticals Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Torrent Pharmaceuticals Ltd Stock Performance
Get live Torrent Pharmaceuticals Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹3,175Day's Price Range₹3,25952 Week's Low
52 Week's High
₹2,755.952-Week Price Range₹3,590.7
| Returns % | |
| 1 Month Return | + 0.23 % |
| 3 Month Return | + 6.07 % |
| 1 Year Return | + 12.85 % |
| 3 Year Return | + 131.07 % |
| 5 Year Return | + 164.09 % |
| Market Stats | |
| Previous Close | ₹3,258.80 |
| Open | ₹3,175.00 |
| Volume | 4.13L |
| Upper Circuit | ₹3,584.60 |
| Lower Circuit | ₹2,933.00 |
Torrent Pharmaceuticals Ltd Fundamentals & Key Indicators
Check Torrent Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,10,074.44 Cr
Return on Equity (ROE)
20.43
PE Ratio (TTM)
57.6
Return on capital employed (ROCE)
20.4
Industry PE ratio
57.39
Beta (LTM)
0.61
P/B Ratio
12.89
Dividend Yield
1.08
PEG Ratio
7.65
Quarterly Earnings Growth YOY
10.91
EPS (TTM)
48.94
Sector
Pharmaceuticals
Book Value
202.57
Technical Analysis
Bullish
View Technical Analysis
How to invest in Torrent Pharmaceuticals Ltd?
Investing in Torrent Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Torrent Pharmaceuticals Ltd or TORNTPHARM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Torrent Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Torrent Pharmaceuticals Ltd with just a few clicks!
Torrent Pharmaceuticals Ltd Stock's Interest Amongst Investors
Torrent Pharmaceuticals Ltd Valuation
Track how Torrent Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Torrent Pharmaceuticals Ltd in the last 5 years
Lowest (31.60x)
April 2, 2018
Industry (57.39x)
June 13, 2025
Today (57.60x)
June 13, 2025
Highest (73.85x)
April 3, 2019
Today’s Price to Earnings Ratio: 57.60x
Torrent Pharmaceuticals Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Torrent Pharmaceuticals Ltd.
based on 28 analysts
64.29%
Buy
21.43%
Hold
14.29%
Sell
64.29% of analysts recommend a 'BUY' rating for Torrent Pharmaceuticals Ltd. Average target price of ₹3593.68
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Share Price Target
Get share price movements and forecasts by analysts on Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd price forecast by 28 analysts
Upside of10.49%
High
₹4232
Target
₹3593.68
Low
₹2930
Torrent Pharmaceuticals Ltd target price ₹3593.68, a slight upside of 10.49% compared to current price of ₹3252.5. According to 28 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Torrent Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:35.62%
Forecast
Actual
Including amortisation and stock based compensations
Torrent Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:83.31%
Forecast
Actual
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Financial Results
Get the annual and quarterly financial summary of Torrent Pharmaceuticals Ltd, including revenue, profit, loss and more.
Indices Featuring Torrent Pharmaceuticals Ltd Stock
Check stock indices that include Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd Earnings Results
Torrent Pharmaceuticals Ltd’s net profit jumped 10.91% since last year same period to ₹498Cr in the Q4 2024-2025. On a quarterly growth basis, Torrent Pharmaceuticals Ltd has generated -0.99% fall in its net profits since last 3-months.
Read More about Earnings ResultsTorrent Pharmaceuticals Ltd Dividends January,2025
In the quarter ending December 2024, Torrent Pharmaceuticals Ltd has declared dividend of ₹26 - translating a dividend yield of 1.66%.
Read More about Dividends
Torrent Pharmaceuticals Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Torrent Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.31% | 0.00 | |
| Foreign Institutions | 16.31% | 0.00 | |
| Mutual Funds | 5.03% | 0.00 | |
| Retail Investors | 7.03% | 0.00 | |
| Others | 3.33% | 0.00 |
Torrent Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Torrent Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 1,10,074.44 | 32.82% | 0.67 | 1,656 | 10,727 | |
| HOLD | 1,76,987.90 | 37.1% | 0.50 | 1,600 | 7,845 | |
| BUY | 42,669.32 | -1.66% | 0.58 | 1,297 | 14,755 | |
| HOLD | 27,838.89 | -1.43% | 0.50 | 772 | 5,664 | |
| BUY | 1,21,573.55 | 26.77% | 0.50 | 4,155 | 25,774 |
Torrent Pharmaceuticals Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Gains for Fifth Straight Session - 09 Jun, 2025
Torrent Pharmaceuticals Ltd rose 0.03% today, marking its fifth consecutive gain. The stock is up 10.17% over the past year, outperforming NIFTY and Nifty Pharma indices. However, it has dropped 2.55% in the last month.Torrent Pharmaceuticals Faces Decline Amid Mixed Financials - 22 May, 2025
Torrent Pharmaceuticals shares fell by 2.02% to Rs 3222.50, making it one of the top losers. Despite revenue growth, net profit slightly decreased, and net cash flow remains negative.Torrent Pharma Reports Strong Q4 Results and Growth - 21 May, 2025
Torrent Pharmaceuticals reported a 10.91% rise in Q4 net profit to ₹498 crore, with strong revenue growth. The board approved a ₹5,000 crore fundraising plan and appointed a new managing director. Analysts maintain positive outlook with target prices around ₹3,670 to ₹4,000.Torrent Pharma Reports Growth and Leadership Changes - 20 May, 2025
Torrent Pharmaceuticals reported a 15.4% increase in FY25 net profit to ₹1,911 crore, driven by strong sales in key markets. The company also announced plans to raise funds and appointed Aman Mehta as Managing Director effective August 2025.
Insights on Torrent Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 4.88% to 5.03% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, TORNTPHARM stock has moved up by 2.3%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 16.17% to 16.31% in Mar 2025 quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, TORNTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.84K Cr → 2.94K Cr (in ₹), with an average increase of 3.4% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 68.31% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 32.4%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 7.17% to 7.03% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 503.0 Cr → 498.0 Cr (in ₹), with an average decrease of 1.0% per quarter
About Torrent Pharmaceuticals Ltd
The company is focused on producing high-quality, affordable medicines for the treatment of a wide range of diseases. Its top products include cardiovascular drugs, antibiotics, anti-diabetic drugs, anti-inflammatory drugs, and anti-infective drugs. Popular brands include Cadila, Torleva, Torlip, and Torleva XR.
Revenue: ₹2,909.00Cr as on March 2025 (Q4 FY25)
Net Profit: ₹498.00Cr as on March 2025 (Q4 FY25)
Listing date: 03 Nov, 1994
Chairperson Name: Sudhir Mehta
| Organisation | Torrent Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Sudhir Mehta |
| E-voting on shares | Click here to vote |
Mutual Funds that own Torrent Pharmaceuticals Ltd
Check out the Mutual Funds with significant holdings in Torrent Pharmaceuticals Ltd.
FAQs
What is Torrent Pharmaceuticals Ltd share price today?
Torrent Pharmaceuticals Ltd share price today stands at ₹3252.5, Open: ₹3175, Previous Close: ₹3258.8, High: ₹3259, Low: ₹3175, 52 Week High: ₹3590.7, 52 Week Low: ₹2755.9.
What is today's traded volume of Torrent Pharmaceuticals Ltd?
Today's traded volume of Torrent Pharmaceuticals Ltd is 4.13L. Which means that 4.13L shares of Torrent Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
What is Torrent Pharmaceuticals Ltd's market cap today?
Today's market capitalisation of Torrent Pharmaceuticals Ltd is ₹1,10,074.44 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Torrent Pharmaceuticals Ltd?
Torrent Pharmaceuticals Ltd’s 52 week high is ₹3590.7 and 52 week low is ₹2755.9. The current share price of Torrent Pharmaceuticals Ltd is ₹3252.5, which is -9.42% down from its 52 week high and 18.02% up from its 52 week low.